摘要
目的:对依达拉奉治疗急性脑梗死临床观察进行Meta分析。方法:收集国内2004～2008年发表发表的依达拉奉治疗急性脑梗死临床观察报告,以Meta分析对19项研究进行同质性检验和合并效应量的估计。结果:①同质性检验,x^2=25.5166,P>0.05。②合并效应量的估计OR合并95%可信区间2.034～3.004,OR合并检验x^2=71.6119,P<0.001。结论:依达拉奉治疗急性脑梗死安全、有效。
Objective：To examine the effects of edaravone on the treatment of acute cerebral infarction（ACI）. Method：By overally collecting clinical reports of edaravone to treat ACI from 2004 to 2008,the meta-analysis was used to make an estimation of homogeneity tests and overall effects of 19 research findings.Result：Homogeneity test：χ^2 = 25.5166,P〉0.05;estimation of merging effect value：OR merging 95%confidence interval was 2.034 - 3.004;OR merging test：χ^2 =71.6119,P〈0.001.Conclusion：Edaravone is effective and safe in the treatment of ACI
出处
《药物流行病学杂志》
CAS
2009年第6期411-413,共3页
Chinese Journal of Pharmacoepidemiology
